Skip to content

Clinical trials

Phase 1 Lupus Erythematosus, Systemic trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Phase: Phase 1 Country / region: United States Clear all

104 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20022
20031
20042
20051
20062
20075
20081
20094
20102
20113
20122
20133
20144
20155
20164
20175
20187
20195
20213
20223
20235
20248
202516
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed52
Recruiting21
Terminated14
Withdrawn5
Active, not recruiting5
Enrolling by invitation3
Unknown status3
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen10
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)6
Bristol-Myers Squibb5
GlaxoSmithKline3
Pfizer3
AbbVie2
AstraZeneca2
Biogen2
Cugene Inc.2
Hospital for Special Surgery, New York2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic104
Lupus Nephritis21
Autoimmune Diseases16
Scleroderma, Systemic16
Arthritis, Rheumatoid13
Myositis10
Dermatomyositis9
Sjogren's Syndrome7
Scleroderma, Diffuse6
Lupus Erythematosus, Discoid5

Trials

Showing 1 to 25 of 104. Each trial links to its page on Pharma Observatory.

4 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.